Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 4.580
-0.010 (-0.22%)
Mar 2, 2026, 5:21 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.81 billion as of March 2, 2026. Its market cap has decreased by -15.85% in one year.
Market Cap
1.81B
Enterprise Value
1.68B
Revenue
62.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.58
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.81B, an increase of 706.52%. That is a compound annual growth rate of 15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.81B | -14.04% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.44B |
| Flerie AB | 2.85B |
| Vicore Pharma Holding AB | 2.83B |
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.19B |
| Genovis AB (publ.) | 1.14B |